Published in Leukemia on August 17, 2006
PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers. Haematologica (2010) 1.83
CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells. Blood (2007) 1.69
FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia. Blood (2008) 1.67
Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells. Blood (2009) 1.62
Shrinkage-based diagonal discriminant analysis and its applications in high-dimensional data. Biometrics (2009) 1.10
A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia. Clin Cancer Res (2009) 0.98
PIM kinase (and Akt) biology and signaling in tumors. Pharmacol Ther (2015) 0.97
Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA. Haematologica (2009) 0.95
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells. Haematologica (2011) 0.93
FcR-like 2 Inhibition of B cell receptor-mediated activation of B cells. J Immunol (2010) 0.90
Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia. PLoS One (2012) 0.88
Proteomic characterization of HIV-modulated membrane receptors, kinases and signaling proteins involved in novel angiogenic pathways. J Transl Med (2009) 0.85
The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells. Leukemia (2015) 0.84
C6-ceramide nanoliposomes target the Warburg effect in chronic lymphocytic leukemia. PLoS One (2013) 0.83
CHES1/FOXN3 regulates cell proliferation by repressing PIM2 and protein biosynthesis. Mol Biol Cell (2014) 0.82
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia. Epigenetics (2013) 0.80
Negative selection of chronic lymphocytic leukaemia cells using a bifunctional rosette-based antibody cocktail. BMC Biotechnol (2008) 0.79
Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemia. PLoS One (2013) 0.78
CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemia. Oncotarget (2016) 0.76
Ligation of human Fc receptor like-2 by monoclonal antibodies down-regulates B-cell receptor-mediated signalling. Immunology (2014) 0.75
The role of PIM1/PIM2 kinases in tumors of the male reproductive system. Sci Rep (2016) 0.75
Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus. Oncotarget (2017) 0.75
An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell (1986) 5.22
Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Diabetes Care (1996) 2.11
Use of X-linked markers for forensic purposes. Int J Legal Med (2003) 1.91
Myopathy and malignant hyperpyrexia. Lancet (1970) 1.87
The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element. Proc Natl Acad Sci U S A (1991) 1.74
Estimation of weights and tensions and apparent involvement of a "sense of effort". Exp Neurol (1974) 1.67
Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers. J Pathol (2006) 1.66
Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways. Syst Biol (Stevenage) (2006) 1.63
Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea. Diabetes Obes Metab (2008) 1.58
Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia. Leuk Res (2010) 1.51
Alternative pathways for the in vivo repair of O6-alkylguanine and O4-alkylthymine in Escherichia coli: the adaptive response and nucleotide excision repair. EMBO J (1988) 1.51
Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arterioscler Thromb Vasc Biol (2001) 1.48
Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia (2005) 1.47
Cardiogenic brain embolism: role of anticoagulants. Aust N Z J Med (1989) 1.39
Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation. Leukemia (2012) 1.35
Immune brachial plexus neuropathy: suggestive evidence for an inflammatory-immune pathogenesis. Neurology (1996) 1.33
The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia. Leukemia (2010) 1.25
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia. Leukemia (2002) 1.21
Differential expression of chemokine receptors in B cell malignancies. Leukemia (2001) 1.20
Bone marrow fibroblasts induce expression of PI3K/NF-kappaB pathway genes and a pro-angiogenic phenotype in CLL cells. Leuk Res (2008) 1.19
O(6)-methyldeoxyguanosine in oesophageal DNA among individuals at high risk of oesophageal cancer. Int J Cancer (1985) 1.17
Threonyl-transfer ribonucleic acid synthetase from Escherichia coli: subunit structure and genetic analysis of the structural gene by means of a mutated enzyme and of a specialized transducing lambda bacteriophage. J Bacteriol (1977) 1.12
Introduction of estrogen-responsiveness into mammalian cell lines. Nucleic Acids Res (1986) 1.11
1,N6-etheno-2'-deoxyadenosine and 3,N4-etheno-2'-deoxycytidine detected by monoclonal antibodies in lung and liver DNA of rats exposed to vinyl chloride. Carcinogenesis (1989) 1.09
Regulation of expression of a human intercellular adhesion molecule (ICAM-1) during lymphohematopoietic differentiation. Blood (1989) 1.08
Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases. Leukemia (2012) 1.07
[Malignant epibulbar tumours: new strategies in diagnostics and therapy]. Klin Monbl Augenheilkd (2011) 1.07
Mechanism of estrogen receptor-dependent transcription in a cell-free system. Mol Cell Biol (1990) 1.07
Improvement in paraplegia in vertebral Paget's disease treated with calcitonin. Br Med J (1976) 1.06
ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia (2003) 1.06
Alteration of structure of level of threonyl-tRNA-synthetase in Borrelidin resistant mutants of E. coli. FEBS Lett (1974) 1.06
Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia (2004) 1.05
Human insulin receptor substrate-2 (IRS-2) is a primary progesterone response gene. Mol Endocrinol (1999) 1.04
A cell-specific activator in the Xenopus A2 vitellogenin gene: promoter elements functioning with rat liver nuclear extracts. EMBO J (1988) 1.03
Elements and factors involved in tissue-specific and embryonic expression of the liver transcription factor LFB1 in Xenopus laevis. Mol Cell Biol (1993) 1.02
Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia. Leukemia (2012) 1.02
Membranous glomerulonephritis and Landry-Guillain-Barre syndrome. Am J Kidney Dis (1986) 1.01
Clinical and mutation data in 12 patients with the clinical diagnosis of Nager syndrome. Hum Genet (2013) 1.00
Eosinophilic meningitis due to Angiostrongylus cantonensis. West J Med (1993) 0.99
Granulocyte-macrophage colony stimulating factor from human lymphocytes. The effect of glycosylation on receptor binding and biological activity. J Biol Chem (1990) 0.99
Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients. Ann Oncol (2011) 0.98
Developmental regulation and tissue distribution of the liver transcription factor LFB1 (HNF1) in Xenopus laevis. Mol Cell Biol (1993) 0.98
Biological effects of stroma-derived factor-1 alpha on normal and CML CD34+ haemopoietic cells. Leukemia (2000) 0.98
The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma. Ann Oncol (2009) 0.97
Human insulin receptor substrate-2: gene organization and promoter characterization. Diabetes (1999) 0.96
Isolation of DICE1: a gene frequently affected by LOH and downregulated in lung carcinomas. Oncogene (1999) 0.96
Identification of a transactivation function in the progesterone receptor that interacts with the TAFII110 subunit of the TFIID complex. J Biol Chem (1995) 0.96
Spontaneous internal carotid artery dissection presenting as hypoglossal nerve palsy. Stroke (1988) 0.95
Intercellular communication between bone marrow stromal cells and CD34+ haematopoietic progenitor cells is mediated by connexin 43-type gap junctions. Br J Haematol (2000) 0.94
Fire eater's risk: lipoid pneumonia following aspiration of a liquid hydrocarbon mixture. Pneumologie (2002) 0.94
Estrogen and progesterone receptor-binding sites on the chicken vitellogenin II gene: synergism of steroid hormone action. Mol Cell Biol (1988) 0.94
Differential constitutive and activation-dependent expression of prion protein in human peripheral blood leucocytes. Br J Haematol (2000) 0.93
Estrogen-inducible derivatives of hepatocyte nuclear factor-4, hepatocyte nuclear factor-3 and liver factor B1 are differently affected by pure and partial antiestrogens. Eur J Biochem (1994) 0.93
Plasma IL-6 concentration is inversely related to insulin sensitivity, and acute-phase proteins associate with glucose and lipid metabolism in healthy subjects. Diabetes Obes Metab (2005) 0.93
Exercise increases insulin clearance in healthy man and insulin-dependent diabetes mellitus patients. Clin Physiol (1997) 0.92
Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain. Neuroscience (2010) 0.92
Genetic analysis of mutations causing borrelidin resistance by overproduction of threonyl-transfer ribonucleic acid synthetase. J Bacteriol (1980) 0.92
Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients. J Antimicrob Chemother (2005) 0.91
CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus. Clin Exp Immunol (2006) 0.91
Role of DNA repair in carcinogen-induced ras mutation. Mutat Res (2000) 0.91
Non-coordinate regulation of enzymes involved in transfer RNA metabolism in Escherichia coli. Biochim Biophys Acta (1980) 0.91
Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus. Scand J Immunol (2007) 0.90
DNA excision repair profiles of normal and leukemic human lymphocytes: functional analysis at the single-cell level. Cancer Res (1997) 0.90
Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients. Diabetes Care (1999) 0.90
Bone marrow-derived stem cells and "plasticity". Ann Hematol (2003) 0.90
Differential expression of drug-resistance-related genes between sensitive and resistant blasts in acute myeloid leukemia. Acta Haematol (2006) 0.89
Graves' disease and Hashimoto's thyroiditis in monozygotic twins: case study as well as transcriptomic and immunohistological analysis of thyroid tissues. Eur J Endocrinol (2006) 0.89
Is it possible to differentiate mtDNA by means of HVIII in samples that cannot be distinguished by sequencing the HVI and HVII regions? Forensic Sci Int (2000) 0.89
Fatty acid transport protein-1 mRNA expression in skeletal muscle and in adipose tissue in humans. Am J Physiol Endocrinol Metab (2000) 0.89
Postmarathon paradox: insulin resistance in the face of glycogen depletion. Am J Physiol (1996) 0.89
A highly specific and sensitive monoclonal antibody detecting histidine-tagged recombinant proteins. Protein Eng (1995) 0.89
The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia. Leukemia (2011) 0.89
Dyslipidemia and a reversible decrease in insulin sensitivity induced by therapy with 13-cis-retinoic acid. Diabetes Metab Res Rev (2001) 0.88
Serum leptin concentration and fuel homeostasis in healthy man. Eur J Clin Invest (1997) 0.87
The "additional subunit" CF0II of the photosynthetic ATP-synthase and the thylakoid polypeptide, binding ferredoxin NADP reductase: are they different? Z Naturforsch C (1991) 0.85
Alteration of the intracellular concentration of aminoacyl-tRNA synthetases and isoaccepting tRNAs during amino-acid limited growth in Escherichia coli. Eur J Biochem (1978) 0.85
E1A-mediated repression of progesterone receptor-dependent transactivation involves inhibition of the assembly of a multisubunit coactivation complex. Mol Cell Biol (2000) 0.85
Acid sphingomyelinase deficiency protects from cisplatin-induced gastrointestinal damage. Oncogene (2008) 0.84
Identity testing in cervical carcinoma in case of suspected mix-up. Int J Gynecol Pathol (2000) 0.84